Analysis on the clinical efficacy and safety of high-dose melphalan pretreatment regimen in autologous hema-topoietic stem cell transplantation for multiple myeloma

XIE Yan-mei; HUANG Yu-kui; HUANG Cai-xian

doi:10.3969/j.issn.1674-3806.2023.11.08

Home>Articles>Analysis on the clinical efficacy and safety of high-dose melphalan pretreatment regimen in autologous hema-topoietic stem cell transplantation for multiple myeloma

DOI: 10.3969/j.issn.1674-3806.2023.11.08

Analysis on the clinical efficacy and safety of high-dose melphalan pretreatment regimen in autologous hema-topoietic stem cell transplantation for multiple myeloma

XIE Yan-mei

HUANG Yu-kui

HUANG Cai-xian

Keywords：High-dose melphalan(HDM)Multiple myeloma(MM)Autologous hematopoietic stem cell transplantation(auto-HSCT)Pretreatment

Publication Date：2023-11-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 1142-1147 )

Chinese Journal of New Clinical Medicine

ISTIC

ISSN：1674-3806

Year, Vol.(Issue)：2023,16(11)